22-01-2009: Eden Biodesign announced the appointment of Maria Lusk as Director of Client Management at its US subsidiary, Eden Biodesign, Inc. Maria’s appointment marks the formal establishment of the company’s US project management function, and coincides with the expansion of the US office, as Eden Biodesign, Inc. this week formally moves to North Carolina’s biotech hub, Research Triangle Park, North Carolina.
Maria brings to Eden Biodesign an in-depth knowledge of biotechnology and pharmaceutical markets, combined with extensive project management, business development, cGMP manufacturing and business development experience. This has been acquired over her 17 year career within the biotechnology and pharmaceutical industry.
Most recently, Maria was Project Manager and Business Development Manager at PharmaDirections Inc., where she spearheaded project management tasks for key clients and established a number of processes, tools and templates for the company, including business development and project management. Previous to this, a significant proportion of Maria’s career was spent at Diosynth Biotechnology, where she held senior positions in global and regional project development, following successful roles in sales support and programme co-ordination. Maria also held roles at Bayer Corporation and LabCorp.
Maria’s appointment also marks the opening of new US facilities at the company. Dr Crawford Brown, CEO and founder of Eden Biodesign commented: “We are pleased to relocate to Research Triangle Park, one of the oldest, largest and most prestigious science parks in North America. The move marks a significant growth period for Eden Biodesign as we continue to accelerate our North America expansion plans and our place in Research Triangle confirms that Eden Biodesign is recognised as one of the key players in the industry”.
This is where you can add this news to your personal favourites
Oxford Expression Technologies (OET) and Eden Biodesign have announced that they have signed a co-marketing agreement. Under the terms of the agreement, OET will offer its customers access to Eden Biodesign’s process development, clinical trial cGMP manufacturing and analytical development ... more
Eden Biodesign announced a management restructure to include the appointment of Dr Derek Ellison as Chief Operating Officer (COO). The restructure results in changes in responsibility for seven executive and senior management members, to support growing demand as Eden continues to expand g ... more
Eden Biodesign announced the appointment of Maria Lusk as Director of Client Management at its US subsidiary, Eden Biodesign, Inc. Maria’s appointment marks the formal establishment of the company’s US project management function, and coincides with the expansion of the US office, as Eden ... more
Eden Biodesign is a successful international biopharmaceutical development and manufacturing services business that provides 'state of the art' development and manufacturing services to biotech clients across Europe, the USA and Asia. It promises all clients a committed service plus the kno ... more